LDC-backed RDi, a leader in data driven, automated self-sampling kits for healthcare, is pleased to announce the successful acquisition of Inicio Health, a pioneering force in healthcare interoperability, automation and AI solutions.
The acquisition unites two forward-thinking companies with a shared mission of delivering smarter, more accessible people-centric pathways for screening, diagnostics, and preventative healthcare.
By combining RDi’s expertise in self-sampling and testing kits with Inicio Health’s cutting-edge digital interoperability and transformation solutions, the partnership will drive significant advancements in the way people access and engage with healthcare. Patients will benefit from seamless digital experiences, increased accessibility, and more efficient diagnostics all with the convenience of self-testing at home. For example, one of Inicio Health’s products, +Cura, a comprehensive digital platform which enables communication between patients, laboratories and clinicians, provides customers with a seamless experience to order, track, and trace diagnostic test kits. This capability will enable RDi to deliver an integrated, end-to-end pathway solution, significantly improving user convenience, operational efficiency, and patient outcomes.
Under this new structure, James Davis, Co-founder and CEO of Inicio Health, will join RDi as Chief Technology Officer (CTO), bringing with him deep expertise in digital health innovation and patient-centric technology. Amanda Sparkes, Co-Founder and Chief Clinical Officer, will join RDi as Chief Clinical Officer and brings 26 years of experience across health systems in defining services and pathways, further strengthening RDi’s healthcare focused leadership. Together, the two companies will accelerate the development of advanced digital solutions which empower individuals to take control of their health, while also enabling healthcare providers to deliver more efficient and scalable care. Inicio Health also encompasses a number of core products such as incioAutomate, inicioPages and inicioHub, all of which support healthcare systems to improve their interoperability and ultimately improve clinical outcomes.
David Cahill, CEO of RDi, commented: “This is a truly exciting moment for RDi and for the future of digitally driven prevention and self-sampling. Inicio Health has built an outstanding reputation for their interoperability solutions which take away many of the pain points faced by healthcare providers and CIOs. By bringing our companies together, we are creating a unique end- to-end diagnostics offering allowing the individual, the laboratory and the provider to access testing and information more seamlessly. This acquisition allows us to expand our capabilities, enhance patient engagement, and ultimately improve health outcomes at scale.”
James Davis, Co-founder and CEO of Inicio Health, added: “Inicio Health was founded on the principle of improving the digital systems that healthcare providers use and therefore empowering systems to be joined up and ultimately seamless for the good of each and every one of us. By joining forces with RDi, we can supercharge that vision by integrating our expertise in healthcare systems with RDi’s home testing, screening, pathology and self-sampling, to create truly end-to-end healthcare solutions. I’m thrilled to take on the role of CTO at RDi and drive the next generation of digital health technologies including automation and AI solutions.”
Aylesh Patel, Partner and Head of South at LDC, added: “This is a key milestone for RDi and represents a significant step in the expansion of its services and capabilities. The adoption of digital technologies is transforming the accessibility of healthcare for patients, and combining RDi’s strengths in automated self-sampling with Inicio Health’s expertise in digital interoperability and AI-driven solutions creates a compelling proposition. We look forward to continuing to support David and the rest of the management team on their exciting growth journey.”
This acquisition, RDi’s third since LDC’s investment in September 2021, represents a major step forward in the evolution of end-to-end self-sampling pathways in healthcare, ensuring that both companies’ combined expertise will continue to push boundaries in screening, diagnostics, and remote patient care.
RDi is a UK-based healthcare and medical devices company specialising in data-driven, automated solutions including fulfilment services for diagnostics and medical kitting. Established in 2004, RDi has become a leader in delivering highly personalised and scalable solutions for healthcare providers including the NHS.